London, 26 June 2025 – G Square Healthcare Private Equity LLP (“G Square”) announces the acquisition of a majority stake in G21 S.r.l. (“G21” or the “Company”). Based in San Possidonio (Modena, Italy), G21 develops, manufactures and distributes proprietary biomaterial solutions for orthopaedic and spine applications.

Founded in 2009, G21 is recognized for its innovation in bone cements, modular spacers for shoulder, knee and hip applications, as well as in minimally invasive surgical solutions for kyphoplasty and vertebroplasty. Over the past decade, the Company has built a strong reputation for its proprietary technologies and has grown rapidly in Italy, the United States and internationally, serving surgeons and healthcare providers in 55 countries.

G Square will partner with G21’s founders Filippo and Maurizio Foroni, as well as with the senior advisor Luigi Ferrari, and they will continue to lead the Company. G Square will support G21 in its next phase of growth, with a particular focus on accelerating international expansion, especially in the United States, strengthening its global distribution network and delivering a rich R&D pipeline.

Filippo Foroni, CEO of G21, commented: “We are excited to join forces with G Square, whose deep healthcare expertise and international footprint make them an ideal partner for G21 in its next phase of growth. This partnership will allow us to boost our international expansion ambitions and continue to provide best-in-class solutions for patients and surgeons worldwide.”

Dr Laurent Ganem, Founder and CEO of G Square, commented: “We have been impressed by G21’s innovation and success to date, we see a strong entrepreneurial culture and very significant potential. We are looking forward to supporting Filippo and the G21 team in their growth ambitions, building on their innovation leadership.”

The terms of the transaction were not disclosed.

For further information, please contact:
Renaud Dessertenne, Partner
+44 20 3757 0160
contact@gsquarecapital.com

About G21


G21 is an Italian medical technology company focused on developing, manufacturing and distributing proprietary biomaterial equipment and solutions for orthopaedic and spine applications, in particular spacers, bone cement, spine devices and mixing & injection systems. With a strong commitment to research, quality, and surgical precision, G21 serves healthcare providers globally through a network of specialized partners and distributors. www.g-21.it